RARA and non-small cell lung carcinoma: Utilizing publicly available transcriptomics, we found an increase in both CMA score and NCoR1/RARα expression ratio in NSCLC cell lines, compared to non-tumorigenic lung cell lines (Fig. EV1C–F; Appendix Table S1).